Teva Stock Has More Than Doubled in a Year. Where Will It Be in 3 Years?

Key PointsTeva's pivot from generic drugs to branded drugs has fueled an 100% surge for shares over the past year.

Doc ban tin day du cua Veytics

Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.